Candon, David, et al. “Modelling the Cost-Effectiveness of Adjuvant Lapatinib for Early-Stage Breast Cancer”. Acta Oncologica, vol. 53, no. 2, Feb. 2014, pp. 201-8, doi:10.3109/0284186X.2013.840740.